Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

Related Posts

• IGBA Calls on all Stakeholders to Join the Biosimilars… 1 November 2021 Read more
• Biosimilars in the EU – Information guide for healthcare… 8 February 2021 Open unofficial Ukrainian translation
• The European Commission needs to prioritise equitable access… 25 January 2022 Over 15 years ago, the world’s first biosimilar was launched.…
• IGBA Launches First Global Biosimilars Week 16 November 2020